QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
NASDAQ:CLRB

Cellectar Biosciences - CLRB Earnings Date, Estimates & Call Transcripts

$5.85
-0.02 (-0.34%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.63
$5.90
50-Day Range
$3.57
$6.23
52-Week Range
$3.37
$10.90
Volume
30,005 shs
Average Volume
20,922 shs
Market Capitalization
$35.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.25

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(May. 10)
-$1.00 Beat By $0.10
Consensus EPS
(May. 10)
-$1.10
Last Year's Q2 EPS
(5/9/2021)
-$1.30
Skip Charts & View Estimated and Actual Earnings Data

CLRB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLRB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellectar Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.11)($0.11)($0.11)
Q2 20221($0.11)($0.11)($0.11)
Q3 20221($1.25)($1.25)($1.25)
Q4 20221($1.12)($1.12)($1.12)
FY 20224($2.59)($2.59)($2.59)
Q1 20231($0.60)($0.60)($0.60)
Q2 20231($0.62)($0.62)($0.62)
Q3 20231($0.63)($0.63)($0.63)
Q4 20231($0.21)($0.21)($0.21)
FY 20234($2.06)($2.06)($2.06)

CLRB Earnings Date and Information

Cellectar Biosciences last released its quarterly earnings results on May 10th, 2022. The biopharmaceutical company reported ($1.00) earnings per share for the quarter, topping the consensus estimate of ($1.10) by $0.10. Cellectar Biosciences has generated ($4.22) earnings per share over the last year (($4.22) diluted earnings per share). Earnings for Cellectar Biosciences are expected to grow in the coming year, from ($4.28) to ($3.39) per share. Cellectar Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off prior year's report dates.

Cellectar Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2022
(Estimated)
        
5/10/2022Q1 2022($1.10)($1.00)+$0.10($0.10)    
3/21/2022Q4 2021($1.00)($1.00)($0.10)
11/7/20219/30/2021($1.10)($1.00)+$0.10($0.10)
8/8/20216/30/2021($1.10)($1.10)($0.11)
5/9/20213/31/2021($1.00)($1.30)($0.30)($0.13)
3/1/202112/31/2020($1.50)($0.70)+$0.80($0.07)
11/14/20209/30/2020($2.00)($1.50)+$0.50($0.15)  
8/10/20206/30/2020($2.80)($2.60)+$0.20($0.26)
5/7/20203/31/2020($3.50)($4.20)($0.70)($0.42)
3/9/202012/31/2019($3.70)($3.30)+$0.40($0.33)
11/12/2019Q3 2019($3.80)($4.20)($0.40)($0.42)
8/12/2019Q2 2019($6.95)($4.60)+$2.35($0.46)
5/6/2019Q1 2019($7.40)($7.60)($0.20)($0.76)
11/13/2018Q3 2018($8.30)($16.50)($8.20)($1.65)
8/10/2018Q2 2018($21.00)($16.90)+$4.10($1.69)
5/11/2018Q1 2018($20.00)($21.00)($1.00)($0.21)
3/21/2018Q4 2017($23.00)($34.00)($11.00)($34.00)  
11/9/2017Q3 2017($25.00)($26.00)($1.00)($0.26)
8/14/2017Q2 2017($24.00)($23.00)+$1.00($0.23)
5/11/2017Q1 2017($23.00)($24.00)($1.00)($0.24)
3/15/2017Q4 2016($23.00)($35.00)($12.00)($0.36)
11/10/2016Q3 2016($20.00)($43.00)($23.00)($0.43)
8/11/2016Q2 2016($40.00)($49.00)($9.00)($0.49)
5/12/2016Q1 2016$91.00+$91.00$0.91
11/12/2015Q315($25.00)($25.00)($0.25)  
8/12/2015Q215($30.00)($30.00)($0.30)  
5/21/2015Q115($30.00)($30.00)($0.30)  
3/24/2015Q4 2014($220.00)($220.00)($2.20)
11/11/2014Q3 2014($100.00)($100.00)($1.00)
8/20/2014Q2 2014($660.00)($660.00)($5.90)
5/14/2014Q1 2014($1,000.00)($1,000.00)($10.00)
3/25/2014Q4 2013($800.00)($1,000.00)($200.00)($6.00)
11/6/2013Q3 2013($1,000.00)($1,400.00)($400.00)$2.00$92.67 million
8/12/2013Q2 2013($1,000.00)($1,000.00)($12.00)
5/15/2013Q1 2013($800.00)($1,200.00)($400.00)($10.00)
5/4/2012Q1 2012($1,200.00)($1,180.00)+$20.00($11.60)
3/9/2012Q4 2011($1,200.00)($1,200.00)($12.00)
11/7/2011Q3 2011($1,420.00)($1,420.00)($14.20)
8/18/2011Q2 2011($2,020.00)($2,020.00)($20.20)












Cellectar Biosciences Earnings - Frequently Asked Questions

When is Cellectar Biosciences's earnings date?

Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates. Learn more on CLRB's earnings history.

Did Cellectar Biosciences beat their earnings estimates last quarter?

In the previous quarter, Cellectar Biosciences (NASDAQ:CLRB) reported ($1.00) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.10) by $0.10. Learn more on analysts' earnings estimate vs. CLRB's actual earnings.

How can I listen to Cellectar Biosciences's earnings conference call?

The conference call for Cellectar Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Cellectar Biosciences's conference call transcript?

The conference call transcript for Cellectar Biosciences's latest earnings report can be read online. Read Transcript

How much profit does Cellectar Biosciences generate each year?

Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$24.12 million. CLRB has generated -$4.22 earnings per share over the last four quarters.

What is Cellectar Biosciences's EPS forecast for next year?

Cellectar Biosciences's earnings are expected to grow from ($4.28) per share to ($3.39) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CLRB) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.